MedPath

Study of effectiveness of topical phenytoin in healing of diabetic foot ulcers

Phase 4
Conditions
Health Condition 1: E086- Diabetes mellitus due to underlying condition with other specified complications
Registration Number
CTRI/2024/02/062560
Lead Sponsor
Tata Motors Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All patients with diabetic foot ulcer

irrespective of gender.

2. Both Inpatients and outpatients with Diabetic

foot ulcer.

Exclusion Criteria

1. Ulcers of other etiology.

2. Other comorbid conditions like renal failure,

generalized debility which adversely affect

wound healing.

3. Patients allergic to phenytoin .

4. patients who are immunocompromised or under

immunosuppression therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath